The Government may have taken money from the DHB hospital budget to increase PHARMAC's funding

30 November 2022 -  In this year’s budget, the Government said it has increased PHARMAC's funding by 43% over the ...

Read more →

PHARMAC seeks feedback on the funding of paediatric cancer medicines

2 November 2022 - PHARMAC is seeking feedback on rule 8.1b of the Pharmaceutical Schedule – a unique exception that ...

Read more →

Budget October 2022–23: strengthening Medicare

25 October 2022 - The Australian Government’s 2022-23 Budget begins the task of strengthening Medicare after a decade of cuts and ...

Read more →

Senator Collins, Representative Eshoo decry Medicare coverage rejection of Alzheimer’s drugs

18 October 2022 - “It’s not CMS’ job to deny the use under the Medicare program of an FDA-approved drug.” – ...

Read more →

Mental health funding of £1.8 million welcomed by NICE and MHRA to explore regulation of digital mental health tools

10 October 2022 - NICE and the MHRA have been awarded £1.8 million funding by Wellcome over three years to explore ...

Read more →

More medicines for New Zealanders, thanks to Government’s Budget boost

28 September 2022 - Health Minister Andrew Little is welcoming news that two more important medicines are set to be ...

Read more →

Half of GPs say staying open is financially unsustainable as Medicare rebate fails

28 September 2022 - Staying in general practice is financially unsustainable for almost half of the nation’s GPs due to ...

Read more →

PHARMAC seeking feedback on nusinersen sodium and adrenaline auto-injectors funding

28 September 2022 - PHARMAC has initiated two consultations today, seeking feedback on the funding of two different medicines that we've ...

Read more →

GPs demand action to fix ‘disintegrating’ Medicare

17 August 2022 - Doctors have issued the federal government with an urgent demand for more Medicare funding, warning general ...

Read more →

COVID antivirals available by telehealth phone consultation

16 July 2022 - Medicare will cover a long consultation by a GP for the purpose of prescribing COVID-19 antivirals, with ...

Read more →

PHARMAC opens door to funding Keytruda in 'biggest step forward in treatment of lung cancer'

6 July 2022 - Keytruda has been called a 'miracle' drug, and there's a glimmer of hope now for those ...

Read more →

PHARMAC considering funding new medicines for lung cancer

6 July 2022 - PHARMAC is seeking proposals from pharmaceutical suppliers for medicines that could treat New Zealanders with lung ...

Read more →

From FDA to MHRA: are drug regulators for hire?

29.June 2022 - Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit ...

Read more →

The Innovative Medicines Fund - good news for patients but has an opportunity been missed to be more ambitious?

27 June 2022 - NHS England and Improvement has announced the launch of the Innovative Medicines Fund. The ABPI’s Director ...

Read more →

Subsidy for medicine for Duchenne muscular dystrophy expires

16 June 2022 - The TLV has decided that Translarna, which is subsidised for patients with Duchenne muscular dystrophy, will not ...

Read more →